FDA, Generic Medicine and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Generic Medicine

Pharmaceutical Companies

STAT+: FTC warns drugmakers they can face legal action over improper patent listings

STAT

SEPTEMBER 14, 2023

The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers.

Generic Medicine

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies FDA

Why are clinical trials struggling with diversity?

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging

Packaging Vaccines Generic Medicine Compounding

Pharmacy Technician Pulse

STAT+: FTC warns drugmakers they can face legal action over improper patent listings

Why are clinical trials struggling with diversity?

Stay Connected